Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival

Operative mortality rate is high in patients receiving MB for the treatment of vasoplegia after cardiopulmonary bypass. Early administration of MB improves survival and reduces the risk-adjusted rate of major adverse events in these patients.